findmyKOL

Shahla Abedi, MD

Basic profile

Ophthalmology

ORCIDNone on fileNPI
RegionAliso Viejo, CA · WestSpecialtyOphthalmologyFocusOphthalmology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication1989Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Shahla Abedi is an Ophthalmology physician. OpenAlex indexes 6 publications with 259 citations (h-index 4).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
6publications

Distinct works indexed by OpenAlex.

259citations

Total citations across indexed works.

4h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
3companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

15 Mareblu
Suite 260
Aliso Viejo, CA 926563015

Telephone

949-831-4144

Registry record last updated 17 Jul 2008.

View the NPPES registry record

Industry payments

3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    46.1%
    Lymphocyte Function-Associated Antigen-1 Antagonist16.7%
    Xiidra100%
    Part D<11 patients
    Prostaglandin Analog11.8%
    Latanoprost100%
    Part D11 patients

    + 3 more classes in this area

  • Cancer & immunology

    42.7%
    Calcineurin inhibitor42.7%
    Restasis77%Cyclosporine23%
    Part D<11 patients
  • Cardiovascular

    7.6%
    Beta blocker7.6%
    Timolol Maleate100%
    Part D<11 patients
Where care is delivered (Part B), 20190% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

1 more publication behind the reveal.Reveal →

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”